glp-1 for high blood pressure drugs improve liver and heart health Hypertension: GLP-1s Like Ozempic, Wegovy

There is no official guidance supporting microdosing practices, and such approaches would fall outside regulatory recommendations

Available at: Novo Nordisk

The mean relative reduction in liver fat at 24 weeks was 82.4% for the 12 mg dose

How to Switch The transition is straightforward: Stopping Saxenda: No taper required Can stop after last daily dose No withdrawal effects Starting semaglutide: Begin at starting dose (0.25mg weekly) Follow standard titration schedule Some providers start at higher doses for patients switching from other GLP-1s, but standard titration is safest Timing: Can start semaglutide the week after stopping Saxenda No mandatory washout period Some providers start immediately after last Saxenda dose What to Expect During transition: Appetite suppression may temporarily decrease during early semaglutide titration GI side effects may recur as you adjust to new medication Full semaglutide effect takes 4-5 months to reach After transition: Most patients see additional weight loss beyond what Saxenda achieved Weekly dosing is typically more convenient Similar ongoing management Transition Considerations Timing expectations: Dont expect immediate additional weight loss Titration period is necessary even for patients experienced with GLP-1s Full benefit of switch becomes apparent at maintenance doses Managing expectations: Some initial adjustment period is normal The convenience benefit is immediate Weight loss benefit develops over months Practical Considerations for Each Medication Understanding day-to-day use helps set expectations

Human trials are ongoing, but even modest effects in opioid use disorder could be clinically meaningful given the favorable safety profile of GLP-1 drugs compared with existing treatments

They also lower levels of glucagon, a hormone that raises blood sugar